Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia

被引：3
|
作者：
Gudkov, A. V. [1 ]
机构：
[1] Siberian State Med Univ, Fed Agcy Hlth Care & Social Dev, Tomsk, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2009年 / 148卷 / 02期
关键词：
adenoma of the prostate; benign prostatic hyperplasia; afala; LUTS;
D O I：
10.1007/s10517-009-0695-8
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The use of ultralow doses of antibodies to prostate-specific antigen (afala) for long-term treatment of benign prostatic hyperplasia in patients with moderate symptoms rapidly and effectively reduces irritative and obstructive symptoms, significantly decreases residual urine volume, and increases the rate of urination. Afala therapy is indicated for patients with stage I-II benign prostatic hyperplasia of moderately pronounced symptoms.
引用
收藏
页码：308 / 311
页数：4
相关论文
共 50 条
  • [1] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    A. V. Gudkov
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [2] LONG-TERM EXPERIENCE WITH THE PROSTATIC SPIRAL FOR URINARY RETENTION DUE TO BENIGN PROSTATIC HYPERPLASIA
    GUAZZONI, G
    MONTORSI, F
    COLOMBO, R
    DIGIROLAMO, V
    DAPOZZO, L
    RIGATTI, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, 25 (01): : 21 - 24
  • [3] Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
    Chughtai, Bilal
    Elterman, Dean S.
    Lee, Richard
    Te, Alexis E.
    Kaplan, Steven A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 267 - 272
  • [4] Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
    Johansen, Truls E. Bjerklund
    Istad, Jan Anders
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (02): : 124 - 131
  • [5] The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
    Rachael L. DiSantostefano
    Andrea K. Biddle
    John P. Lavelle
    PharmacoEconomics, 2006, 24 : 171 - 191
  • [6] Clinical Study of the Efficiency and Safety of Afala in Patients with Benign Prostatic Hyperplasia
    K. V. Savel’eva
    M. V. Kachanova
    V. N. Pavlov
    R. A. Kazikhinurov
    M. Yu. Frolov
    A. B. Mukhin
    V. V. Udut
    Z. A. Yurmazov
    Yu. L. Dugina
    S. A. Sergeeva
    O. I. Epshtein
    Bulletin of Experimental Biology and Medicine, 2009, 148 : 305 - 307
  • [7] Clinical Study of the Efficiency and Safety of Afala in Patients with Benign Prostatic Hyperplasia
    Savel'eva, K. V.
    Kachanova, M. V.
    Pavlov, V. N.
    Kazikhinurov, R. A.
    Frolov, M. Yu.
    Mukhin, A. B.
    Udut, V. V.
    Yurmazov, Z. A.
    Dugina, Yu. L.
    Sergeeva, S. A.
    Epshtein, O. I.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (02) : 305 - 307
  • [8] LONG-TERM TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH ALFUZOSIN - A 24-30-MONTH SURVEY
    JARDIN, A
    BENSADOUN, H
    DELAUCHECAVALLIER, MC
    STALLABOURDILLON, A
    ATTALI, P
    SULHER, A
    TOUBOL, J
    RAMPAL, M
    JURASCHECK, F
    COLOBY, P
    GATTEGNO, B
    ZIPFEL, A
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (05): : 579 - 584
  • [9] Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia
    Metcalfe C.
    Poon K.S.
    Current Urology Reports, 2011, 12 (4) : 265 - 273
  • [10] Long-term (4 year) efficacy and tolerability of doxazosin for the treatment of concurrent benign prostatic hyperplasia and hypertension
    Fawzy, A
    Hendry, A
    Cook, E
    Gonzalez, F
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (07) : 346 - 354
12345